{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:17:50Z","timestamp":1788214670061,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"36","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,22]]},"DOI":"10.1038\/s41388-026-03912-8","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:12:48Z","timestamp":1785233568000},"page":"3797-3811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator"],"prefix":"10.1038","volume":"45","author":[{"given":"Anniek","family":"Zaalberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Lacoste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Minnee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mayayo-Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karianne","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9209-5403","authenticated-orcid":false,"given":"Sebastian","family":"Gregoricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs A.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3552-6390","authenticated-orcid":false,"given":"Liesbeth","family":"Hoekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-3807","authenticated-orcid":false,"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2754-4150","authenticated-orcid":false,"given":"Cor","family":"Lieftink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-9321","authenticated-orcid":false,"given":"Stefan","family":"Prekovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Proost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4756-843X","authenticated-orcid":false,"given":"Serge","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5093-5945","authenticated-orcid":false,"given":"Maarten","family":"Altelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-5726","authenticated-orcid":false,"given":"Peter S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0116-4130","authenticated-orcid":false,"given":"Roderick L.","family":"Beijersbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9823-7289","authenticated-orcid":false,"given":"Wilbert","family":"Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5223-2549","authenticated-orcid":false,"given":"Andries M.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"3912_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"3912_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.canlet.2015.12.022","volume":"380","author":"SL Shiao","year":"2016","unstructured":"Shiao SL, Chu GCY, Chung LWK. Regulation of prostate cancer progression by the tumor microenvironment. Cancer Lett. 2016;380:340\u20138.","journal-title":"Cancer Lett"},{"key":"3912_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","volume":"24","author":"J Stultz","year":"2021","unstructured":"Stultz J, Fong L. How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2021;24:697\u2013717.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3912_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2017","unstructured":"Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2017;15:11\u201324.","journal-title":"Nat Rev Urol"},{"key":"3912_CR5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1464-410X.2010.09804.x","volume":"107","author":"N Nonomura","year":"2010","unstructured":"Nonomura N, Takayama H, Nakayama M, Nakai Y, Kawashima A, Mukai M, et al. Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU Int. 2010;107:1918\u201322.","journal-title":"BJU Int"},{"key":"3912_CR6","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.18632\/oncotarget.14185","volume":"8","author":"A Maolake","year":"2017","unstructured":"Maolake A, Izumi K, Shigehara K, Natsagdorj A, Iwamoto H, Kadomoto S, et al. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22\u2013CCR4 axis. Oncotarget. 2017;8:9739.","journal-title":"Oncotarget"},{"key":"3912_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray PJ. Macrophage Polarization. Annu Rev Physiol. 2017;79:541\u201366.","journal-title":"Annu Rev Physiol"},{"key":"3912_CR8","first-page":"1","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6:1\u201312.","journal-title":"Signal Transduct Target Ther"},{"key":"3912_CR9","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3390\/cancers13081946","volume":"13","author":"E Cendrowicz","year":"2021","unstructured":"Cendrowicz E, Sas Z, Bremer E, Rygiel TP. The role of macrophages in cancer development and therapy. Cancers. 2021;13:1946.","journal-title":"Cancers"},{"key":"3912_CR10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/1541-7786.MCR-20-0740","volume":"19","author":"JC Siefert","year":"2021","unstructured":"Siefert JC, Cioni B, Muraro MJ, Alshalalfa M, Vivie J, van der Poel HG, et al. The prognostic potential of human prostate cancer-associated macrophage subtypes as revealed by single-cell transcriptomics. Mol Cancer Res. 2021;19:1778\u201391.","journal-title":"Mol Cancer Res"},{"key":"3912_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/1477-3163.83937","volume":"10","author":"P Lonergan","year":"2011","unstructured":"Lonergan P, Tindall D. Androgen receptor signaling in prostate cancer development and progression. J Carcinog. 2011;10:20.","journal-title":"J Carcinog"},{"key":"3912_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/er.2002-0032","volume":"25","author":"CA Heinlein","year":"2004","unstructured":"Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25:276\u2013308.","journal-title":"Endocr Rev"},{"key":"3912_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","volume":"606","author":"X Guan","year":"2022","unstructured":"Guan X, Polesso F, Wang C, Sehrawat A, Hawkins RM, Murray SE, et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 2022;606:791\u20136.","journal-title":"Nature"},{"key":"3912_CR14","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1158\/0008-5472.CAN-12-3228","volume":"73","author":"LY Fang","year":"2013","unstructured":"Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto H, et al. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. Cancer Res. 2013;73:5633\u201346.","journal-title":"Cancer Res"},{"key":"3912_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18313-y","volume":"11","author":"B Cioni","year":"2020","unstructured":"Cioni B, Zaalberg A, van Beijnum JR, Melis MHM, van Burgsteden J, Muraro MJ, et al. Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion. Nat Commun. 2020;11:1\u201317.","journal-title":"Nat Commun"},{"key":"3912_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34:184\u201391.","journal-title":"Nat Biotechnol"},{"key":"3912_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson KR, Hanna RE, Hegde M, Donovan KF, Strand C, Sullender ME, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018;9:1\u201315.","journal-title":"Nat Commun"},{"key":"3912_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3912_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15:554.","journal-title":"Genome Biol"},{"key":"3912_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature. 2021;595:730\u20134.","journal-title":"Nature"},{"key":"3912_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343:84\u201387.","journal-title":"Science"},{"key":"3912_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2018.05.037","volume":"174","author":"D Takeda","year":"2018","unstructured":"Takeda D, Spis\u00e1k S, Seo J, Bell C, O\u2019Connor E, Korthauer K, et al. A somatically acquired enhancer of the androgen receptor is a noncoding driver in advanced prostate cancer. Cell. 2018;174:422\u201332.","journal-title":"Cell"},{"key":"3912_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:1\u20137.","journal-title":"Sci Rep"},{"key":"3912_CR24","doi-asserted-by":"crossref","unstructured":"Schmidt U, Weigert M, Broaddus C, Myers G. Cell detection with star-convex polygons. In: Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2018. Vol. 11071. Springer: Cham, Switzerland; 2018. pp 265\u201373","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"3912_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-4939-3049-4_17","volume":"1355","author":"RR Jersie-Christensen","year":"2016","unstructured":"Jersie-Christensen RR, Sultan A, Olsen JV. Simple and reproducible sample preparation for single-shot phosphoproteomics with high sensitivity. Methods Mol Biol. 2016;1355:251\u201360.","journal-title":"Methods Mol Biol"},{"key":"3912_CR26","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteom. 2014;13:2513\u201326.","journal-title":"Mol Cell Proteom"},{"key":"3912_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0022-1759(96)00056-7","volume":"193","author":"N Van Rooijen","year":"1996","unstructured":"Van Rooijen N, Sanders A, Van Den Berg TK. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods. 1996;193:93\u201399.","journal-title":"J Immunol Methods"},{"key":"3912_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","volume":"174","author":"NVan Rooijen","year":"1994","unstructured":"Rooijen NVan, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83\u201393.","journal-title":"J Immunol Methods"},{"key":"3912_CR29","doi-asserted-by":"crossref","unstructured":"Isra\u00ebl A. The IKK complex, a central regulator of NF-\u03baB activation. Cold Spring Harb Perspect Biol. 2010;2:a000158.","DOI":"10.1101\/cshperspect.a000158"},{"key":"3912_CR30","doi-asserted-by":"publisher","first-page":"32107","DOI":"10.1074\/jbc.M504432200","volume":"280","author":"AE Santiago-Walker","year":"2005","unstructured":"Santiago-Walker AE, Fikaris AJ, Kao GD, Brown EJ, Kazanietz MG, Meinkoth JL. Protein kinase C delta stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest. J Biol Chem. 2005;280:32107\u201314.","journal-title":"J Biol Chem"},{"key":"3912_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1158\/0008-5472.CAN-05-2539","volume":"66","author":"NA Riobo","year":"2006","unstructured":"Riobo NA, Haines GM, Emerson CP. Protein kinase C-delta and mitogen-activated protein\/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Res. 2006;66:839\u201345.","journal-title":"Cancer Res"},{"key":"3912_CR32","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1100\/tsw.2010.214","volume":"10","author":"A Basu","year":"2010","unstructured":"Basu A, Pal D. Two faces of protein kinase c\u03b4: the contrasting roles of PKC\u03b4 in cell survival and cell death. ScientificWorldJOURNAL. 2010;10:2272\u201384.","journal-title":"ScientificWorldJOURNAL"},{"key":"3912_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/2049-632X.12210","volume":"72","author":"M Amaya","year":"2014","unstructured":"Amaya M, Keck F, Bailey C, Narayanan A. The role of the IKK complex in viral infections. Pathog Dis. 2014;72:32\u201344.","journal-title":"Pathog Dis"},{"key":"3912_CR34","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.2741\/3385","volume":"14","author":"ME Reyland","year":"2009","unstructured":"Reyland ME. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci. 2009;14:2386\u201399.","journal-title":"Front Biosci"},{"key":"3912_CR35","doi-asserted-by":"publisher","first-page":"16251","DOI":"10.1073\/pnas.0703496104","volume":"104","author":"A Schwegmann","year":"2007","unstructured":"Schwegmann A, Guler R, Cutler AJ, Arendse B, Horsnell WGC, Flemming A, et al. Protein kinase C \u03b4 is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes. Proc Natl Acad Sci USA. 2007;104:16251\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3912_CR36","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/eji.201040985","volume":"41","author":"R Guler","year":"2011","unstructured":"Guler R, Afshar M, Arendse B, Parihar SP, Revaz-Breton M, Leitges M, et al. PKC\u03b4 regulates IL-12p40\/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis. Eur J Immunol. 2011;41:706\u201315.","journal-title":"Eur J Immunol"},{"key":"3912_CR37","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1038\/sj.onc.1208676","volume":"24","author":"B De Servi","year":"2005","unstructured":"De Servi B, Hermani A, Medunjanin S, Mayer D. Impact of PKC\u03b4 on estrogen receptor localization and activity in breast cancer cells. Oncogene. 2005;24:4946\u201355.","journal-title":"Oncogene"},{"key":"3912_CR38","doi-asserted-by":"crossref","unstructured":"Page K, Li J, Corbit KC, Rumilla KM, Soh JW, Weinstein IB et al. Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-\u03b4. Am J Respir Cell Mol Biol. 2002;27:204\u201313.","DOI":"10.1165\/ajrcmb.27.2.20010016oc"},{"key":"3912_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1096\/fj.03-0979rev","volume":"18","author":"DN Jackson","year":"2004","unstructured":"Jackson DN, Foster DA. The enigmatic protein kinase C\u03b4: complex roles in cell proliferation and survival. FASEB J. 2004;18:627\u201336.","journal-title":"FASEB J"},{"key":"3912_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/A:1021640817208","volume":"8","author":"C Brodie","year":"2003","unstructured":"Brodie C, Blumberg PM. Regulation of cell apoptosis by protein kinase c \u03b4. Apoptosis. 2003;8:19\u201327.","journal-title":"Apoptosis"},{"key":"3912_CR41","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1074\/jbc.271.10.5325","volume":"271","author":"MF Denning","year":"1996","unstructured":"Denning MF, Dlugosz AA, Threadgill DW, Magnuson T, Yuspa SH. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C \u03b4. J Biol Chem. 1996;271:5325\u201331.","journal-title":"J Biol Chem"},{"key":"3912_CR42","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35072063","volume":"2","author":"J Smeitink","year":"2001","unstructured":"Smeitink J, Van Den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet. 2001;2:342\u201352.","journal-title":"Nat Rev Genet"},{"key":"3912_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","volume":"20","author":"N Parameswaran","year":"2010","unstructured":"Parameswaran N, Patial S. Tumor necrosis factor-\u03b1 signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20:87.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"3912_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-01199-8","volume":"8","author":"SJ Oh","year":"2022","unstructured":"Oh SJ, Ikeda M, Ide T, Hur KY, Lee MS. Mitochondrial event as an ultimate step in ferroptosis. Cell Death Discov. 2022;8:1\u201313.","journal-title":"Cell Death Discov"},{"key":"3912_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9061505","volume":"9","author":"AM Battaglia","year":"2020","unstructured":"Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and cancer: mitochondria meet the \u201ciron maiden\u201d cell death. Cells. 2020;9:1\u201326.","journal-title":"Cells"},{"key":"3912_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-6-39","volume":"6","author":"U Jariwala","year":"2007","unstructured":"Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, et al. Identification of novel androgen receptor target genes in prostate cancer. Mol Cancer. 2007;6:1\u201315.","journal-title":"Mol Cancer"},{"key":"3912_CR47","doi-asserted-by":"crossref","unstructured":"Sayar E, Patel RA, Coleman IM, Roudier MP, Zhang A, Mustafi P et al. Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer. JCI Insight. 2023;8:e162907.","DOI":"10.1172\/jci.insight.162907"},{"key":"3912_CR48","doi-asserted-by":"crossref","unstructured":"Kim JK, Jung JH, Shin DH, You HJ, Cha S, Song BS et al. Rapid androgen-responsive proteome is involved in prostate cancer progression. Biomedicines. 2021;9:1877.","DOI":"10.3390\/biomedicines9121877"},{"key":"3912_CR49","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/OTT.S254995","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li Y, Zhang R, Wang F, Wang T, Jiao Y. The role of erastin in ferroptosis and its prospects in cancer therapy. Onco Targets Ther. 2020;13:5429.","journal-title":"Onco Targets Ther"},{"key":"3912_CR50","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1158\/2159-8290.CD-21-0576","volume":"12","author":"S Linder","year":"2022","unstructured":"Linder S, Hoogstraat M, Stelloo S, Eickhoff N, Schuurman K, de Barros H, et al. Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer toward androgen independence. Cancer Discov. 2022;12:2074\u201397.","journal-title":"Cancer Discov"},{"key":"3912_CR51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173\u201384.","journal-title":"Hepatology"},{"key":"3912_CR52","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fnins.2018.00466","volume":"12","author":"M Abdalkader","year":"2018","unstructured":"Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR. Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci. 2018;12:466.","journal-title":"Front Neurosci"},{"key":"3912_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2020","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2020;31:107\u201325.","journal-title":"Cell Res"},{"key":"3912_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8580043","volume":"2022","author":"C Han","year":"2022","unstructured":"Han C, Deng Y, Xu W, Liu Z, Wang T, Wang S, et al. The roles of tumor-associated macrophages in prostate cancer. J Oncol. 2022;2022:8580043.","journal-title":"J Oncol"},{"key":"3912_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00247","volume":"9","author":"CH Lo","year":"2018","unstructured":"Lo CH, Lynch CC. Multifaceted roles for macrophages in prostate cancer skeletal metastasis. Front Endocrinol. 2018;9:1.","journal-title":"Front Endocrinol"},{"key":"3912_CR56","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/cancers14020440","volume":"14","author":"C Martori","year":"2022","unstructured":"Martori C, Sanchez-Moral L, Paul T, Pardo JC, Font A, de Porras VR, et al. Macrophages as a therapeutic target in metastatic prostate cancer: a way to overcome immunotherapy resistance? Cancers. 2022;14:440.","journal-title":"Cancers"},{"key":"3912_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2018.00049","volume":"8","author":"AR Poh","year":"2018","unstructured":"Poh AR, Ernst M. Targeting macrophages in cancer: from bench to bedside. Front Oncol. 2018;8:49.","journal-title":"Front Oncol"},{"key":"3912_CR58","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/0008-5472.CAN-14-0992","volume":"75","author":"J Escamilla","year":"2015","unstructured":"Escamilla J, Schokrpur S, Liu C, Priceman SJ, Moughon D, Jiang Z, et al. CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Res. 2015;75:950.","journal-title":"Cancer Res"},{"key":"3912_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"MA Cannarile","year":"2017","unstructured":"Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, R\u00fcttinger D. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer. 2017;5:53.","journal-title":"J Immunother Cancer"},{"key":"3912_CR60","doi-asserted-by":"publisher","first-page":"14404","DOI":"10.1073\/pnas.222537099","volume":"99","author":"H Ide","year":"2002","unstructured":"Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, et al. Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci USA. 2002;99:14404\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3912_CR61","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1200\/JCO.20.02759","volume":"39","author":"SR Denmeade","year":"2021","unstructured":"Denmeade SR, Wang H, Agarwal N, Smith DC, Schweizer MT, Stein MN, et al. TRANSFORMER: a randomized phase II study comparing bipolar androgen therapy versus enzalutamide in asymptomatic men with castration-resistant metastatic prostate cancer. J Clin Oncol. 2021;39:1371.","journal-title":"J Clin Oncol"},{"key":"3912_CR62","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.eururo.2020.06.042","volume":"79","author":"MC Markowski","year":"2021","unstructured":"Markowski MC, Wang H, Sullivan R, Rifkind I, Sinibaldi V, Schweizer MT, et al. A multicohort open-label phase II trial of bipolar androgen therapy in men with metastatic castration-resistant prostate cancer (RESTORE): a comparison of post-abiraterone versus post-enzalutamide cohorts. Eur Urol. 2021;79:692\u20139.","journal-title":"Eur Urol"},{"key":"3912_CR63","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18:309\u201324.","journal-title":"Nat Rev Immunol"},{"key":"3912_CR64","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.4049\/jimmunol.170.11.5681","volume":"170","author":"K Page","year":"2003","unstructured":"Page K, Li J, Zhou L, Iasvoyskaia S, Corbit KC, Soh J-W, et al. Regulation of airway epithelial cell NF-\u03baB-dependent gene expression by protein kinase C\u03b4. J Immunol. 2003;170:5681\u20139.","journal-title":"J Immunol"},{"key":"3912_CR65","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.3390\/ijms130910697","volume":"13","author":"D Cosentino-Gomes","year":"2012","unstructured":"Cosentino-Gomes D, Rocco-Machado N, Meyer-Fernandes JR. Cell signaling through protein kinase C oxidation and activation. Int J Mol Sci. 2012;13:10697.","journal-title":"Int J Mol Sci"},{"key":"3912_CR66","doi-asserted-by":"publisher","first-page":"38982","DOI":"10.1074\/jbc.M506767200","volume":"280","author":"AM Gonzalez-Guerrico","year":"2005","unstructured":"Gonzalez-Guerrico AM, Kazanietz MG. Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta. J Biol Chem. 2005;280:38982\u201391.","journal-title":"J Biol Chem"},{"key":"3912_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0076-6879(08)01607-8","volume":"446","author":"L Xiao","year":"2008","unstructured":"Xiao L, Caino MC, von Burstin VA, Oliva JL, Kazanietz MG. Phorbol ester-induced apoptosis and senescence in cancer cell models. Methods Enzymol. 2008;446:123\u201339.","journal-title":"Methods Enzymol"},{"key":"3912_CR68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/mc.20476","volume":"48","author":"L Xiao","year":"2009","unstructured":"Xiao L, Gonzalez-Guerrico A, Kazanietz MG. PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens. Mol Carcinog. 2009;48:187\u201395.","journal-title":"Mol Carcinog"},{"key":"3912_CR69","doi-asserted-by":"publisher","first-page":"pe27","DOI":"10.1126\/stke.2882005pe27","volume":"2005","author":"DK Biswas","year":"2005","unstructured":"Biswas DK, Singh S, Shi Q, Pardee AB, Iglehart JD. Crossroads of estrogen receptor and NF-kappaB signaling. Sci STKE. 2005;2005:pe27.","journal-title":"Sci STKE"},{"key":"3912_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/mend.12.1.0044","volume":"12","author":"LI McKay","year":"1998","unstructured":"McKay LI, Cidlowski JA. Cross-talk between nuclear factor-\u03baB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol. 1998;12:45\u201356.","journal-title":"Mol Endocrinol"},{"key":"3912_CR71","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/nar\/gkw855","volume":"45","author":"M Malinen","year":"2017","unstructured":"Malinen M, Niskanen EA, Kaikkonen MU, Palvimo JJ. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-\u03baB cistrome to reprogram the prostate cancer cell transcriptome. Nucleic Acids Res. 2017;45:619.","journal-title":"Nucleic Acids Res"},{"key":"3912_CR72","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cyto.2013.09.003","volume":"64","author":"G Rodr\u00edguez-Berriguete","year":"2013","unstructured":"Rodr\u00edguez-Berriguete G, S\u00e1nchez-Espiridi\u00f3n B, Cansino JR, Olmedilla G, Mart\u00ednez-Onsurbe P, S\u00e1nchez-Chapado M, et al. Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-\u03b1 signaling pathways in prostate cancer. Cytokine. 2013;64:555\u201363.","journal-title":"Cytokine"},{"key":"3912_CR73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature08782","volume":"464","author":"M Ammirante","year":"2010","unstructured":"Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature. 2010;464:302\u20135.","journal-title":"Nature"},{"key":"3912_CR74","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL. Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene. 1999;18:6853\u201366.","journal-title":"Oncogene"},{"key":"3912_CR75","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM. Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways. Biochem Soc Trans. 2015;43:621\u20136.","journal-title":"Biochem Soc Trans"},{"key":"3912_CR76","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1242\/jcs.058537","volume":"122","author":"SK Niture","year":"2009","unstructured":"Niture SK, Jain AK, Jaiswal AK. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-\u03b4-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci. 2009;122:4452\u201364.","journal-title":"J Cell Sci"},{"key":"3912_CR77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.15252\/emmm.201404181","volume":"7","author":"Y Jin","year":"2015","unstructured":"Jin Y, Wang L, Qu S, Sheng X, Kristian A, Maelandsmo GM, et al. STAMP2 increases oxidative stress and is critical for prostate cancer. EMBO Mol Med. 2015;7:315\u201331.","journal-title":"EMBO Mol Med"},{"key":"3912_CR78","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/ERC-15-0556","volume":"23","author":"LM Butler","year":"2016","unstructured":"Butler LM, Centenera MM, Swinnen JV. Androgen control of lipid metabolism in prostate cancer: novel insights and future applications. Endocr Relat Cancer. 2016;23:R219\u2013R227.","journal-title":"Endocr Relat Cancer"},{"key":"3912_CR79","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","volume":"9","author":"U Sen","year":"2023","unstructured":"Sen U, Coleman C, Sen T. Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis. Trends Cancer. 2023;9:480\u20139.","journal-title":"Trends Cancer"},{"key":"3912_CR80","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748\u201364.","journal-title":"Cell"},{"key":"3912_CR81","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/2159-8290.CD-24-0559","volume":"15","author":"L Chesner","year":"2025","unstructured":"Chesner L, Polesso F, Graff J, Hawley J, Smith A, Lundberg AJ, et al. Androgen receptor inhibition increases MHC class I expression and improves immune response in prostate cancer. Cancer Discov. 2025;15:481\u201394.","journal-title":"Cancer Discov"},{"key":"3912_CR82","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C, Garc\u00eda-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543\u2013D552.","journal-title":"Nucleic Acids Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03912-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03912-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03912-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:02:42Z","timestamp":1788213762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03912-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":82,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026,9,22]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03912-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EC obtained research support from AbbVie, Genentech, Bayer Pharmaceuticals, Forma Therapeutics, KronoBio, Foghorn, Macrogenics, Gilead, Janssen Research and GSK. AMB obtained research support from Bayer Pharmaceuticals, Sanofi and Astellas Pharma Inc. All other authors have declared no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All animal experiments were approved by the Animal Welfare Committee of the Netherlands Cancer Institute and performed in accordance with institutional, national, and European guidelines for animal research under protocol 9.1.10386 AVD3010020172464. The DARANA trial was approved by the institutional review board of the Netherlands Cancer Institute and written informed consent was signed by all participants enrolled in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}